Cargando…

Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease

Alzheimer’s disease (AD) is an irreversible and progressive neurodegenerative disorder that slowly destroys memory. The precise mechanism of AD is still not entirely understood and remains under discussion; it is believed to be a multifactorial disease in which a number of mechanisms are involved in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabrera-Pardo, Jaime R., Fuentealba, Jorge, Gavilán, Javiera, Cajas, Daniel, Becerra, José, Napiórkowska, Mariola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005051/
https://www.ncbi.nlm.nih.gov/pubmed/32082168
http://dx.doi.org/10.3389/fphar.2019.01679
_version_ 1783494849887993856
author Cabrera-Pardo, Jaime R.
Fuentealba, Jorge
Gavilán, Javiera
Cajas, Daniel
Becerra, José
Napiórkowska, Mariola
author_facet Cabrera-Pardo, Jaime R.
Fuentealba, Jorge
Gavilán, Javiera
Cajas, Daniel
Becerra, José
Napiórkowska, Mariola
author_sort Cabrera-Pardo, Jaime R.
collection PubMed
description Alzheimer’s disease (AD) is an irreversible and progressive neurodegenerative disorder that slowly destroys memory. The precise mechanism of AD is still not entirely understood and remains under discussion; it is believed to be a multifactorial disease in which a number of mechanisms are involved in its pathogenesis. Worldwide, near 37 million people suffer from the effects of AD. As a cause of death for elderly, it is predicted that AD will rank third in the coming years, just behind cancer and heart disease. Unfortunately, AD remains an incurable condition. Despite the devastating problems associated with AD, there are only four FDA approved drugs for palliative treatment of this pathology. Hence, renewed scientific efforts are required not only to uncover more insights into the AD process but also to develop more efficient pharmacological tools against this disease. Due to the complexity and multiple mechanisms at play in the progression of AD, the development of drugs by rational design is extremely difficult. The existing drugs to fight against Alzheimer’s have had limited success, mainly due to their ability to modulate only one of the mechanisms involved in AD. As opposed to single-targeted strategies, the identification of small molecules able to affect multiple pathways involved in Alzheimer’s is a promising strategy to develop more efficient medicines against this disease. Central to existing efforts to develop pharmaceuticals controlling AD is the discovery of new chemicals displaying strong neuroactivity. Benzofurans are privileged oxygen containing heterocycles that have a strong neuroprotective behavior, inhibiting several of the important events involved in the AD process. In this review, an approach is presented that relies on expanding the neuroprotective chemical space of benzofuran scaffolds by accessing them from Andean–Patagonian fungi and synthetic sources (chemical libraries). The exploration of the neuroprotective chemical space of these scaffolds has the potential to allow the discovery of substitution patterns that display multi-target neuroactivity against multiple events involved in AD. This benzofuran chemical framework will establish a multi-target chemical space that could set the basis for the development of super drugs against AD.
format Online
Article
Text
id pubmed-7005051
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70050512020-02-20 Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease Cabrera-Pardo, Jaime R. Fuentealba, Jorge Gavilán, Javiera Cajas, Daniel Becerra, José Napiórkowska, Mariola Front Pharmacol Pharmacology Alzheimer’s disease (AD) is an irreversible and progressive neurodegenerative disorder that slowly destroys memory. The precise mechanism of AD is still not entirely understood and remains under discussion; it is believed to be a multifactorial disease in which a number of mechanisms are involved in its pathogenesis. Worldwide, near 37 million people suffer from the effects of AD. As a cause of death for elderly, it is predicted that AD will rank third in the coming years, just behind cancer and heart disease. Unfortunately, AD remains an incurable condition. Despite the devastating problems associated with AD, there are only four FDA approved drugs for palliative treatment of this pathology. Hence, renewed scientific efforts are required not only to uncover more insights into the AD process but also to develop more efficient pharmacological tools against this disease. Due to the complexity and multiple mechanisms at play in the progression of AD, the development of drugs by rational design is extremely difficult. The existing drugs to fight against Alzheimer’s have had limited success, mainly due to their ability to modulate only one of the mechanisms involved in AD. As opposed to single-targeted strategies, the identification of small molecules able to affect multiple pathways involved in Alzheimer’s is a promising strategy to develop more efficient medicines against this disease. Central to existing efforts to develop pharmaceuticals controlling AD is the discovery of new chemicals displaying strong neuroactivity. Benzofurans are privileged oxygen containing heterocycles that have a strong neuroprotective behavior, inhibiting several of the important events involved in the AD process. In this review, an approach is presented that relies on expanding the neuroprotective chemical space of benzofuran scaffolds by accessing them from Andean–Patagonian fungi and synthetic sources (chemical libraries). The exploration of the neuroprotective chemical space of these scaffolds has the potential to allow the discovery of substitution patterns that display multi-target neuroactivity against multiple events involved in AD. This benzofuran chemical framework will establish a multi-target chemical space that could set the basis for the development of super drugs against AD. Frontiers Media S.A. 2020-01-31 /pmc/articles/PMC7005051/ /pubmed/32082168 http://dx.doi.org/10.3389/fphar.2019.01679 Text en Copyright © 2020 Cabrera-Pardo, Fuentealba, Gavilán, Cajas, Becerra and Napiórkowska http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Cabrera-Pardo, Jaime R.
Fuentealba, Jorge
Gavilán, Javiera
Cajas, Daniel
Becerra, José
Napiórkowska, Mariola
Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease
title Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease
title_full Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease
title_fullStr Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease
title_full_unstemmed Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease
title_short Exploring the Multi–Target Neuroprotective Chemical Space of Benzofuran Scaffolds: A New Strategy in Drug Development for Alzheimer’s Disease
title_sort exploring the multi–target neuroprotective chemical space of benzofuran scaffolds: a new strategy in drug development for alzheimer’s disease
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005051/
https://www.ncbi.nlm.nih.gov/pubmed/32082168
http://dx.doi.org/10.3389/fphar.2019.01679
work_keys_str_mv AT cabrerapardojaimer exploringthemultitargetneuroprotectivechemicalspaceofbenzofuranscaffoldsanewstrategyindrugdevelopmentforalzheimersdisease
AT fuentealbajorge exploringthemultitargetneuroprotectivechemicalspaceofbenzofuranscaffoldsanewstrategyindrugdevelopmentforalzheimersdisease
AT gavilanjaviera exploringthemultitargetneuroprotectivechemicalspaceofbenzofuranscaffoldsanewstrategyindrugdevelopmentforalzheimersdisease
AT cajasdaniel exploringthemultitargetneuroprotectivechemicalspaceofbenzofuranscaffoldsanewstrategyindrugdevelopmentforalzheimersdisease
AT becerrajose exploringthemultitargetneuroprotectivechemicalspaceofbenzofuranscaffoldsanewstrategyindrugdevelopmentforalzheimersdisease
AT napiorkowskamariola exploringthemultitargetneuroprotectivechemicalspaceofbenzofuranscaffoldsanewstrategyindrugdevelopmentforalzheimersdisease